(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E,2R)-4-[(1S,2S,4R)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]but-3-en-2-yl]oxyoxane-3,4,5-triol

Details

Top
Internal ID a9a4c353-51d9-4941-86b3-d5c3e6741a99
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E,2R)-4-[(1S,2S,4R)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]but-3-en-2-yl]oxyoxane-3,4,5-triol
SMILES (Canonical) CC(C=CC12C(CC(O1)CC2(C)O)(C)C)OC3C(C(C(C(O3)CO)O)O)O
SMILES (Isomeric) C[C@H](/C=C/[C@]12[C@@](C[C@H](O1)CC2(C)C)(C)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O
InChI InChI=1S/C19H32O8/c1-10(25-16-15(23)14(22)13(21)12(9-20)26-16)5-6-19-17(2,3)7-11(27-19)8-18(19,4)24/h5-6,10-16,20-24H,7-9H2,1-4H3/b6-5+/t10-,11-,12-,13-,14+,15-,16-,18+,19+/m1/s1
InChI Key PZTDXOPJDHEQOS-MHHOZIMSSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C19H32O8
Molecular Weight 388.50 g/mol
Exact Mass 388.20971797 g/mol
Topological Polar Surface Area (TPSA) 129.00 Ų
XlogP -0.50
Atomic LogP (AlogP) -0.54
H-Bond Acceptor 8
H-Bond Donor 5
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E,2R)-4-[(1S,2S,4R)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]but-3-en-2-yl]oxyoxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.6045 60.45%
Caco-2 - 0.7358 73.58%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.7286 72.86%
Subcellular localzation Mitochondria 0.6341 63.41%
OATP2B1 inhibitior - 0.8580 85.80%
OATP1B1 inhibitior + 0.9005 90.05%
OATP1B3 inhibitior + 0.9132 91.32%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior - 0.8839 88.39%
P-glycoprotein inhibitior - 0.8195 81.95%
P-glycoprotein substrate - 0.8487 84.87%
CYP3A4 substrate + 0.6324 63.24%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8516 85.16%
CYP3A4 inhibition - 0.8815 88.15%
CYP2C9 inhibition - 0.8928 89.28%
CYP2C19 inhibition - 0.9015 90.15%
CYP2D6 inhibition - 0.9391 93.91%
CYP1A2 inhibition - 0.9073 90.73%
CYP2C8 inhibition - 0.7913 79.13%
CYP inhibitory promiscuity - 0.8919 89.19%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.5941 59.41%
Eye corrosion - 0.9909 99.09%
Eye irritation - 0.9593 95.93%
Skin irritation - 0.7700 77.00%
Skin corrosion - 0.9504 95.04%
Ames mutagenesis - 0.6200 62.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4199 41.99%
Micronuclear - 0.7941 79.41%
Hepatotoxicity - 0.8125 81.25%
skin sensitisation - 0.8695 86.95%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.6000 60.00%
Mitochondrial toxicity - 0.5125 51.25%
Nephrotoxicity - 0.7355 73.55%
Acute Oral Toxicity (c) I 0.3888 38.88%
Estrogen receptor binding + 0.5777 57.77%
Androgen receptor binding + 0.6477 64.77%
Thyroid receptor binding + 0.6691 66.91%
Glucocorticoid receptor binding - 0.5065 50.65%
Aromatase binding + 0.6407 64.07%
PPAR gamma + 0.6361 63.61%
Honey bee toxicity - 0.6854 68.54%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.8600 86.00%
Fish aquatic toxicity + 0.7681 76.81%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.61% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 96.83% 95.93%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.10% 91.11%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 91.36% 92.86%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.97% 97.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 88.88% 97.25%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.84% 95.89%
CHEMBL1937 Q92769 Histone deacetylase 2 87.31% 94.75%
CHEMBL3286 P00749 Urokinase-type plasminogen activator 86.76% 97.88%
CHEMBL3401 O75469 Pregnane X receptor 86.10% 94.73%
CHEMBL2581 P07339 Cathepsin D 85.55% 98.95%
CHEMBL1293316 Q9HBX9 Relaxin receptor 1 85.33% 82.50%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.95% 85.14%
CHEMBL2996 Q05655 Protein kinase C delta 84.53% 97.79%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.96% 95.89%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 83.58% 93.10%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.94% 96.47%
CHEMBL2072 P35499 Sodium channel protein type IV alpha subunit 81.55% 92.32%
CHEMBL218 P21554 Cannabinoid CB1 receptor 81.48% 96.61%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.62% 100.00%

Cross-Links

Top
PubChem 53494103
NPASS NPC75441
LOTUS LTS0025603
wikiData Q105217111